13 — HUTCHMED (China) Share News
0.000.00%
Last trade - 00:00- HK$20.35bn
- HK$14.66bn
- $630.20m
REG - Hutchmed China Ltd - Standard form for notification of major holdings
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED to Host Expert Call to discuss ITP
AnnouncementREG - Hutchmed China Ltd - LTIP and Share Option Scheme
AnnouncementREG - Hutchmed China Ltd - 2024 Interim Results and Business Updates
AnnouncementRCS - Hutchmed China Ltd - NDA Acceptance in China for Tazemetostat
AnnouncementRCS - Hutchmed China Ltd - Overseas Regulatory Announcement: Form F-3 Filing
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
AnnouncementREG - Hutchmed China Ltd - Blocklisting Six Monthly Return
AnnouncementREG - Hutchmed China Ltd - HUTCHMED to Announce 2024 HY Financial Results
AnnouncementRCS - Hutchmed China Ltd - Save the Date: HUTCHMED to Present R&D Updates
AnnouncementREG - Hutchmed China Ltd - European Commission Approval for FRUZAQLA
AnnouncementRCS - Hutchmed China Ltd - Lancet Publish Phase III ESLIM-01 Results
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Initiates Phase I Trial of HMPL-506
AnnouncementRCS - Hutchmed China Ltd - Nature Medicine Publish Phase III FRUTIGA Results
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Presentations at 2024 ASCO Annual Meeting
AnnouncementREG - Hutchmed China Ltd - Retirement of Chairman and new Chairman appointed
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Data to be Presented at EHA2024 Congress
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Initiates Phase II/III Trial with Hengrui
Announcement